MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.eclinm.2022.101502

Медицинская библиотека · EClinicalMedicine · 2022

Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria.

Borre Ethan D, Ayer Austin, Der Carolina, Ibekwe Titus, Emmett Susan D, Dixit Siddharth, Shahid Minahil, Olusanya Bolajoko, Garg Suneela, Johri Mohini, Saunders James E, Tucci Debara L, Wilson Blake S, Ogbuoji Osondu, Sanders Schmidler Gillian D

СтатьяПеревод в очереди

Аннотация

BACKGROUND

There is no published decision model for informing hearing health care resource allocation across the lifespan in low- and middle-income countries. We sought to validate the Decision model of the Burden of Hearing loss Across the Lifespan International (DeciBHAL-I) in Chile, India, and Nigeria.

METHODS

DeciBHAL-I simulates bilateral sensorineural hearing loss (SNHL) and conductive hearing loss (CHL) acquisition, SNHL progression, and hearing loss treatment. To inform model inputs, we identified setting-specific estimates including SNHL prevalence from the Global Burden of Disease (GBD) studies, acute otitis media (AOM) incidence and prevalence of otitis-media related CHL from a systematic review, and setting-specific pediatric and adult hearing aid use prevalence. We considered a coefficient of variance root mean square error (CV-RMSE) of ≤15% to indicate good model fit.

FINDINGS: The model-estimated prevalence of bilateral SNHL closely matched GBD estimates, (CV-RMSEs: 3.2-7.4%). Age-specific AOM incidences from DeciBHAL-I also achieved good fit (CV-RMSEs=5.0-7.5%). Model-projected chronic suppurative otitis media prevalence (1.5% in Chile, 4.9% in India, and 3.4% in Nigeria) was consistent with setting-specific estimates, and the incidence of otitis media-related CHL was calibrated to attain adequate model fit. DeciBHAL-projected adult hearing aid use in Chile (3.2-19.7% ages 65-85 years) was within the 95% confidence intervals of published estimates. Adult hearing aid prevalence from the model in India was 1.4-2.3%, and 1.1-1.3% in Nigeria, consistent with literature-based and expert estimates.

INTERPRETATION: DeciBHAL-I reasonably simulates hearing loss natural history, detection, and treatment in Chile, India, and Nigeria. Future cost-effectiveness analyses might use DeciBHAL-I to inform global hearing health policy.

FUNDING: National Institutes of Health (3UL1-TR002553-03S3 and F30 DC019846).

Для цитирования: Borre Ethan D, Ayer Austin, Der Carolina, Ibekwe Titus, Emmett Susan D, Dixit Siddharth, Shahid Minahil, Olusanya Bolajoko, Garg Suneela, Johri Mohini, Saunders James E, Tucci Debara L, Wilson Blake S, Ogbuoji Osondu, Sanders Schmidler Gillian D. Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria.. EClinicalMedicine. 2022. DOI: 10.1016/j.eclinm.2022.101502.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.